AlphAIAlphAI — Financial news for AI agents
yahoo.comSEP 82 min read$MET

Is MetLife Outperforming the Nasdaq?

MetLife (MET) has outperformed the Nasdaq Composite, with shares up 22.5% year-to-date and 32.6% over 52 weeks. The company reported a 15.5% increase in adjusted earnings and 7% revenue growth in Q2 2026. Analysts have a 'Moderate Buy' rating with a mean price target of $106.23.

Original reporting
yahoo.com
Published Sep 8, 2026, 8:15 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 8, 2026, 8:25 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
Is MetLife Outperforming the Nasdaq? — source image
Source · yahoo.com
Decision brief

The 30-second read

$METBullishMed
01

Why it matters

Earnings beat could drive short‑term price appreciation and attract new buying interest.

02

Market read

MET's strong earnings contrast with a declining Nasdaq, offering a relative long opportunity.

03

What to watch

Potential exposure to interest‑rate volatility and underwriting cycles.

Relevance 8/10Novelty 8/10Timing: post‑Q2 2026 earnings release

Background

MetLife reported Q2 2026 results with double‑digit earnings growth and raised analyst price targets.

Company-level read

Ticker impact

$METBullishHigh confidence
Context

Q2 2026 earnings released: adjusted earnings up 15.5% to $1.57B, EPS $2.43, premiums up 7% to $13.7B.

Expected impact

Potential further upside toward $106 target.

Evidence & confidence

Revenue and earnings beat, bullish analyst consensus, price target above current price.

Market effects

Sector

Life‑insurance sector may see relative strength as MET outperforms Nasdaq.

Regional

Positive for U.S. large‑cap insurance stocks.

Global

Highlights resilience of diversified insurers amid broader market weakness.

Counterpoint

What could challenge this read

Valuation may already price in growth; risk of slowdown in premium growth.

Key entities

  • Company
    MetLife, Inc.

    Large‑cap insurer reporting Q2 2026 earnings.

Read at source← All news

Related articles

AUG 13
$METMedAI 8/10

MetLife (MET) Q2 2026 Earnings Call Transcript

MetLife (MET) Q2 2026 earnings call reported adjusted earnings of about $1.6 billion, or $2.43 per share, up 15% year over year. Adjusted premiums, fees and other revenues rose 5% (excluding pension risk transfers). Sales increased 7%, led by international growth. MetLife repurchased about $700 million of shares in the quarter and announced a new $3 billion authorization.

yahoo.com7 min
AUG 8
$METMed

MetLife Q2 Earnings Call Highlights

MetLife (NYSE:MET) reported Q2 expense ratio of 12.1%, up from 11.7% a year ago, citing a ~50 bps PineBridge Investments impact. Management said it is on track to beat its 12.1% full-year 2026 target. Group Benefits adjusted earnings rose to $503m, RIS to $377m, and MIM to $57m, with multiple segment margin and sales updates.

finance.yahoo.com7 min
AUG 7
$METMed

MetLife reports $1.6bn adjusted earnings in second quarter 2026

MetLife reported second-quarter 2026 adjusted earnings of $1.6bn. Net investment income rose 18% to $6.7bn. Book value per share increased 8% to $38.59 and adjusted book value per share rose 3% to $57.71. The company returned over $1.1bn to shareholders via buybacks and dividends, and reported segment adjusted earnings gains across Group Benefits, Retirement and Income Solutions, Asia, EMEA, and MetLife Investment Management.

asiainsurancereview.com2 min
AUG 6
$METMed

Financial results round-up: MetLife, Prudential, Corebridge, Palomar, Heritage, TWFG, Root and more

A financial results roundup covers multiple insurers and MGAs. MetLife reported Q2 net income of $705m and adjusted EPS $2.43. Prudential posted Q2 net income of $985m and record individual life sales. Corebridge reported a $16m net loss and merger approval. Palomar, Heritage, TWFG, Root, Trupanion and Clover Health also reported Q2 figures and guidance updates.

insurancebusinessmag.com9 min
AUG 5
$METMed

METLIFE INC (MET): Results of Operations and Financial Condition

METLIFE INC (MET) filed an SEC Form 8-K — Results of Operations and Financial Condition. Page 1 of 25 Exhibit 99.1 For Immediate Release | Global Communications | MetLife, Inc. MetLife Announces 2Q 2026 Results Strong business momentum continues under New Frontier strategy • Net income increased 1% 1 to $705 million , or $1.09 per share. • Adjusted earnings increased

SEC EDGAR 8-K6 min